Last reviewed · How we verify

NCT07488377

Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease

Not yet recruiting Last updated 23 March 2026
What this trial tests

trial testing Cognitive Self-Efficacy Questionnaire (Turkish Version) in Parkinson Disease in 100 participants. Not yet recruiting.

Timeline
1 April 2026
Primary endpoint
1 January 2027
1 April 2027

Quick facts

Lead sponsorAcibadem University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment100
Start date1 April 2026
Primary completion1 January 2027
Estimated completion1 April 2027

Drugs / interventions tested

Conditions studied

Sponsor

Acibadem University

Who can join

Adults 40 to 85, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the validity and reliability of the Turkish version of the Cognitive Self-Efficacy Questionnaire in individuals with Parkinson's disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Acibadem University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07488377.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing